Results 251 to 260 of about 814,709 (363)

Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome

Arthritis &Rheumatology, Accepted Article.
Background ATP is released from platelets through both degranulation and pannexin‐1 (PANX1) channels. ATP then activates P2X receptors to amplify platelet activation via calcium‐dependent signaling. Objective To evaluate the role of platelet PANX1 channels in the pathophysiology of antiphospholipid syndrome (APS), an acquired thrombo‐inflammatory ...
Bruna de Moraes Mazetto Fonseca, Somanathapura K. NaveenKumar, Srilakshmi Yalavarthi, Kavya Sugur, Thalia G. Newman, Claire K. Hoy, Cyrus Sarosh, Jordan K. Schaefer, Ajay Tambralli, Jacqueline A. Madison, Yu Zuo, Fernanda Orsi, Michael Holinstat, Jason S. Knight   +13 more
wiley   +1 more source

Hemorrhage or thrombosis? Adrenal involvements in a patient with antiphospholipid syndrome. [PDF]

Rheumatol Immunol Res
Liu L, Wang Q, Jiang Y, Huang C.
europepmc   +1 more source

Factors responsible for hepatic artery thrombosis after pediatric liver transplantation. [PDF]

, 1989
Belle, S., Esquivel, C.O., Ferla, G., Kahn, D., Kahn, D., Koneru, B., Makowka, L., Mazzaferro, V., Scantlebury, V.P., Scotti-Foglieni, C.L., Starzl, T.E., Todo, S., Tzakis, A.G.   +12 more
core   +1 more source

Preoperative Prediction of Portal Vein Thrombosis After Right‐Sided Hepatectomy for Perihilar Cholangiocarcinoma [PDF]

Isamu Hosokawa, Tsukasa Takayashiki, Shigetsugu Takano, Mamoru Takada, Shunsuke Nakajima, Gaku TANAKA, Masayuki Ohtsuka   +6 more
openalex   +1 more source

Pelvic Thrombosis [PDF]

Postgraduate Medical Journal, 1954
openaire   +2 more sources

Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole‐blood RNA transcriptome

Arthritis &Rheumatology, Accepted Article.
Objective Antiphospholipid syndrome (APS) is a thrombo‐inflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders targeted treatment. We aimed to identify distinct molecular endotypes among antiphospholipid antibody (aPL)‐positive patients using whole‐blood transcriptomics.
Amala Ambati, Feiyang Ma, Katarina Kmetova, Sherwin Navaz, Claire K. Hoy, Cyrus Sarosh, Ajay Tambralli, Erika Navarro‐Mendoza, Johann E. Gudjonsson, J. Michelle Kahlenberg, Jacqueline A. Madison, Alí Duarte‐García, Jason S. Knight, Yu Zuo   +13 more
wiley   +1 more source

184 Worldwide Heparin Shortage

Research and Practice in Thrombosis and Haemostasis
Maanas Deodhar, Surabhi Fadnavis, Atul Laddu, Jawed Fareed   +3 more
doaj   +1 more source

Massive haematemesis as the first manifestation of superior mesenteric and portal vein thrombosis in a healthy young adult. [PDF]

J Surg Case Rep
Yasin S, Mohammed A, Zohud A, Odeh A, Altarifi A.   +4 more
europepmc   +1 more source

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres

British Journal of Clinical Pharmacology, EarlyView.
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr, Anette D. Kjeldsen, Annette D. Fialla, Anne‐Emmanuelle Fargeton, Alexandre Guilhem, Elisabetta Buscarini, Freya Droege, Guido Manfredi, Hans‐Jurgen Mager, Jean‐Christophe Saurin, Jens Kjeldsen, Josefien Hessels, Marco C. Post, Robert Mandic, Sanne Boerman, Stefan Kasper‐Virchow, Sören Möller, Urban Geisthoff, Sophie Dupuis‐Girod   +18 more
wiley   +1 more source

The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance [PDF]

, 2019
Cosi, E., Ferrari, S., Girolami, A., Randi, M. L.   +3 more
core   +1 more source